J. Goldman & Co’s SteadyMed Ltd STDY Stock Holding History

J. Goldman & Co’s Portfolio STDY Stock Details STDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-116,600	Closed	-$735K	–	449
2017 Q2	$735K	Buy	116,600 +82,679	+244%	+$562K	0.04%	228
2017 Q1	$197K	Buy	+33,921	New	+$113K	0.01%	300

Other funds holding STDY

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Truvvo Partners New York $5.22M AUM 13.74% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return

MCM

Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

J. Goldman & Co's STDY Position: Q3 2017 in Review

J. Goldman & Co sold out of SteadyMed Ltd (STDY) in Q3 2017, closing a stake of 116,600 shares — an estimated $735K sold.

J. Goldman & Co first reported a position in STDY in Q1 2017 and held it in 2 quarters. The position peaked at $735K in Q2 2017. 26 funds tracked by Wall St. Rank hold STDY as of Q3 2017.

J. Goldman & Co reported no remaining SteadyMed Ltd position as of Q3 2017 after selling out during the quarter.
J. Goldman & Co sold 116,600 SteadyMed Ltd shares in Q3 2017, an estimated $735K.
J. Goldman & Co first reported a position in SteadyMed Ltd in Q1 2017 and held it in 2 quarters.
J. Goldman & Co's SteadyMed Ltd position peaked at $735K in Q2 2017.
26 funds tracked by Wall St. Rank held SteadyMed Ltd as of Q3 2017.

Based on J. Goldman & Co's 13F filing for Q3 2017, filed 14 Nov 2017.